Actively Recruiting
Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
Led by PT. Prodia Stem Cell Indonesia · Updated on 2026-02-24
40
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
Sponsors
P
PT. Prodia Stem Cell Indonesia
Lead Sponsor
R
RS Prof. Dr. I.G.N.G Ngoerah
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to compare the effectiveness of secretome injection and intradermal platelet-rich plasma (PRP) injection on hair density and the terminal-to-vellus hair ratio in patients with androgenetic alopecia at Prof. Dr. I.G.N.G. Ngoerah General Hospital.
CONDITIONS
Official Title
Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 25 to 59 years with androgenetic alopecia, Hamilton-Norwood grades II to VI, seeking treatment at Prof. Dr. I.G.N.G. Ngoerah General Hospital
- Female patients aged 25 to 59 years with androgenetic alopecia, Ludwig grades I to III, seeking treatment at the same hospital
- Female patients not currently pregnant or breastfeeding
- Patients who have stopped anti-androgen medication and minoxidil for at least 1 month before treatment
- Patients without known allergies to secretome components or PRP preparation materials
- Patients able to speak Indonesian and willing to give written informed consent
You will not qualify if you...
- Patients unable to speak or understand Indonesian or unwilling to provide written informed consent
- Patients with hair loss types other than androgenetic alopecia
- Patients currently using 5-alpha reductase inhibitors
- Patients who had intradermal corticosteroid injections to the scalp within 6 months before the study
- Patients with active scalp infections or dermatitis
- Patients with known allergies to secretome components or PRP preparation materials
- History of hypertrophic scarring or blood clotting disorders
- Patients unable to complete all study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prof. dr. I.G.N.G. Ngoerah Central General Hospital
Denpasar, Bali, Indonesia, 80113
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here